BioPorto A/S
BIOPOR
Kedudukan dalam Saham
#22972
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Harga Saham
$0.15400149
Modal Pasaran
$76.25M
Perubahan (1 hari)
-5.83%
Perubahan (1 tahun)
-46.53%
Negara
DK
Perdagangan BioPorto A/S (BIOPOR)
Kategori
Healthcare
Sejarah harga saham bagi BioPorto A/S (BIOPOR)
Harga penutupan tertinggi: $0.15 pada 2026-10-01
Harga penutupan terendah: $0.41 pada 2019-12-01
Harga penutupan terendah: $0.41 pada 2019-12-01
Sejarah harga saham BioPorto A/S dari 2019 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -35.32% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $694.53 | 24.47% |
US
|
|
| $234.00 | 5.99% |
US
|
|
| $416.01 | 122.61% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.93 | 22.13% |
US
|
